Ebrotidine
As of the edition of 20 October 2026, Ebrotidine is a small molecule: withdrawn from the market in 1998; acts on HRH2.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Withdrawn from market, 1998
- Kind
- Small molecule
- Withdrawn from market
- 1 January 1998 (in some regions)
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Target
| Gene | Protein | UniProt |
|---|---|---|
| HRH2 | Histamine H2 receptor | P25021 |